119 related articles for article (PubMed ID: 2574742)
1. Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 Dec; 251(3):1187-92. PubMed ID: 2574742
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 Dec; 251(3):1193-8. PubMed ID: 2481031
[TBL] [Abstract][Full Text] [Related]
3. Lack of desensitization of alpha-2-mediated inhibition of lipolysis in fat cells after acute and chronic treatment with clonidine.
Villeneuve A; Carpene C; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1985 May; 233(2):433-40. PubMed ID: 2987483
[TBL] [Abstract][Full Text] [Related]
4. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)].
Berlan M; Lafontan M; Dang Tran L
J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915
[TBL] [Abstract][Full Text] [Related]
5. [Evidence for an alpha 2-blocking property of nicergoline by using antilipolytic alpha-adrenoceptors from adipose tissue].
Carpéné C; Lafontan M; Berlan M
J Pharmacol; 1983; 14(1):57-66. PubMed ID: 6132024
[TBL] [Abstract][Full Text] [Related]
6. [The effect of alpha adrenergic agents on lipolysis in rat adipose tissue; the effect of nonselective alpha adrenomimetics and alpha adrenolytics in an experiment in vitro].
Lincová D; Miseková D; Hynie S
Sb Lek; 1991 Oct; 93(9-10):351-63. PubMed ID: 1687969
[TBL] [Abstract][Full Text] [Related]
7. Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
Galitzky J; Mauriege P; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 May; 249(2):583-91. PubMed ID: 2566681
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog.
Taouis M; Berlan M; Montastruc P; Lafontan M
J Pharmacol Exp Ther; 1988 Dec; 247(3):1172-80. PubMed ID: 2905003
[TBL] [Abstract][Full Text] [Related]
9. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine.
Taouis M; Berlan M; Lafontan M
Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286
[TBL] [Abstract][Full Text] [Related]
10. Lipolysis in rat adipose tissue in vitro and its alpha 2 adrenergic control.
Mühlbachová E; Zámostný V; Kadrabová M; Horný I
Physiol Bohemoslov; 1983; 32(4):359-65. PubMed ID: 6312472
[TBL] [Abstract][Full Text] [Related]
11. Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization.
Berlan M; Carpene C; Lafontan M; Dang-Tran L
Horm Metab Res; 1982 May; 14(5):257-60. PubMed ID: 6284627
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.
Galitzky J; Taouis M; Berlan M; Rivière D; Garrigues M; Lafontan M
Eur J Clin Invest; 1988 Dec; 18(6):587-94. PubMed ID: 2906290
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
Moro C; Crampes F; Sengenes C; De Glisezinski I; Galitzky J; Thalamas C; Lafontan M; Berlan M
FASEB J; 2004 May; 18(7):908-10. PubMed ID: 15033935
[TBL] [Abstract][Full Text] [Related]
15. Interplay of alpha-2 and beta adrenoceptors in the control of free fatty acid release from bone marrow adipose tissue.
Tran MA; Lac DT; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1984 Jul; 230(1):228-31. PubMed ID: 6086878
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
Carpéné C; Galitzky J; Collon P; Esclapez F; Dauzats M; Lafontan M
J Pharmacol Exp Ther; 1993 Apr; 265(1):237-47. PubMed ID: 8097243
[TBL] [Abstract][Full Text] [Related]
17. Influence of androgenic status on the alpha 2/beta-adrenergic control of lipolysis in white fat cells: predominant alpha 2-antilipolytic response in testosterone-treated-castrated hamsters.
Pecquery R; Leneveu MC; Giudicelli Y
Endocrinology; 1988 Jun; 122(6):2590-6. PubMed ID: 2453344
[TBL] [Abstract][Full Text] [Related]
18. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life.
Marcus C; Karpe B; Bolme P; Sonnenfeld T; Arner P
J Clin Invest; 1987 Jun; 79(6):1812-8. PubMed ID: 3034983
[TBL] [Abstract][Full Text] [Related]
19. Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
Moro C; Galitzky J; Sengenes C; Crampes F; Lafontan M; Berlan M
J Pharmacol Exp Ther; 2004 Mar; 308(3):984-92. PubMed ID: 14634036
[TBL] [Abstract][Full Text] [Related]
20. [The role of beta and alpha adrenergic receptors in the lipolytic effect of catecholamines on dog adipocytes (author's transl)].
Berlan M; Dang Tran L
J Physiol (Paris); 1978 Dec; 74(6):601-8. PubMed ID: 218001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
